Talphera, Inc. financial data

Symbol
TLPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
1850 Gateway Drive, Suite 175, San Mateo, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
ACELRX PHARMACEUTICALS INC (to 12/14/2023)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 479 % +99.8%
Debt-to-equity 98.9 % +84.4%
Return On Equity -111 % +13.6%
Return On Assets -56 % +33.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.1M shares +0.76%
Common Stock, Shares, Outstanding 17M shares +0.45%
Entity Public Float 13.2M USD +9.33%
Common Stock, Value, Issued 17K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25.8M shares +81.2%
Weighted Average Number of Shares Outstanding, Diluted 14.3M shares +92.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.72M USD +21.1%
Costs and Expenses 15.3M USD -13%
Operating Income (Loss) -25.7M USD -84.7%
Nonoperating Income (Expense) 2.25M USD -66%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.35M USD -137%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -13M USD +29.3%
Earnings Per Share, Basic -0.5 USD/shares +61.2%
Earnings Per Share, Diluted -0.08 USD/shares +91.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.86M USD +54.9%
Cash, Cash Equivalents, and Short-term Investments 14M USD
Assets, Current 9.42M USD -18.7%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 8.82M USD 0%
Other Assets, Noncurrent 20K USD -88%
Assets 18.2M USD -10.6%
Accounts Payable, Current 670K USD -49.9%
Accrued Liabilities, Current 1.25M USD -48.7%
Liabilities, Current 2.65M USD -41.3%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 10.2M USD +62.7%
Retained Earnings (Accumulated Deficit) -457M USD -2.93%
Stockholders' Equity Attributable to Parent 8M USD -43.3%
Liabilities and Equity 18.2M USD -10.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.88M USD +45.1%
Net Cash Provided by (Used in) Financing Activities 12M USD
Net Cash Provided by (Used in) Investing Activities -2.73M USD -783%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 17M shares +0.45%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.4M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.72M USD -71.8%
Deferred Tax Assets, Valuation Allowance 103M USD +2.86%
Deferred Tax Assets, Gross 105M USD +2.78%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Operating Lease, Liability, Current 51K USD -95.7%
Deferred Tax Assets, Operating Loss Carryforwards 90.1M USD +1.47%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.03M USD +6.91%
Additional Paid in Capital 465M USD +1.51%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 0 USD -100%
Share-based Payment Arrangement, Expense 989K USD -42.8%
Interest Expense 15K USD -98.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%